MedTrace Logo

Transfusion Requirements in Cardiac Surgery III

NCT02042898 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5028

Last updated 2018-08-15

No results posted yet for this study

Summary

TRICS-III is an international, multi-centre, open-label randomized controlled trial of two commonly used transfusion strategies in high risk patients having cardiac surgery using a non-inferiority trial design.

Conditions

  • Disorder; Heart, Functional, Postoperative, Cardiac Surgery

Interventions

OTHER

Restrictive Transfusion Strategy

OTHER

Liberal transfusion strategy

Sponsors & Collaborators

  • Unity Health Toronto

    lead OTHER

Principal Investigators

  • David Mazer, MD · Unity Health Toronto

  • Nadine Shehata, MD · MOUNT SINAI HOSPITAL

  • Richard Whitlock, MD · McMaster University

  • Dean Fergusson, MD · Ottawa Hospital Research Institute

  • Kevin Thorpe, MSc · University of Toronto

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-20
Primary Completion
2017-04-28
Completion
2017-10-01

Countries

  • United States
  • Australia
  • Brazil
  • Canada
  • China
  • Colombia
  • Denmark
  • Egypt
  • Germany
  • Greece
  • India
  • Israel
  • Malaysia
  • New Zealand
  • Romania
  • Singapore
  • South Africa
  • Spain
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02042898 on ClinicalTrials.gov